deoxyuridine has been researched along with Colorectal Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, T; Kataoka, H; Kawaguchi, M; Liu, HS; Nishii, R; Xu, Y | 1 |
| Carlsson, G; Gustavsson, B; Odin, E; Taflin, H; Tell, R; Wettergren, Y | 1 |
| Andersen, EC; García-González, AP; Ritter, AD; Shrestha, S; Walhout, AJM; Yilmaz, LS | 1 |
| Allen, PJ; Balachandran, VP; Boucher, T; Capanu, M; Cercek, A; Chou, JF; D'Angelica, MI; DeMatteo, RP; Jarnagin, WR; Kemeny, NE; Kingham, TP; Pak, LM | 1 |
| Aviñó, A; Eritja, R; Fàbrega, C; Jorge, AF; Pais, AACC | 1 |
| de Klerk, DJ; Honeywell, RJ; Kristensen, MH; Peters, GJ; Sarkisjan, D | 1 |
| Ackland, SP; de Bock, CE; Garg, MB; Lincz, LF; Sakoff, JA; Scorgie, FE; Scott, N | 1 |
| Clarke, SJ; Hoskins, J; Li, KM; Rivory, LP; Sharma, R | 1 |
| Holt, PR; Moss, SF; Scholes, JV | 1 |
| Fukuoka, M; Kudoh, S; Masuda, N; Matsui, K; Myobudani, H; Nakagawa, K; Negoro, S; Nemoto, S; Nihira, S; Nogami, T; Ogawa, K; Okuda, T; Takeda, K; Takifuji, N; Yamada, M; Yamamoto, N | 1 |
| Calvert, AH; Cunningham, D; Farrugia, DC; Ford, HE; Hill, ME; Jackman, AL; Judson, IR; Mitchell, F; Rees, C | 1 |
4 trial(s) available for deoxyuridine and Colorectal Neoplasms
| Article | Year |
|---|---|
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chromatography, Liquid; Colorectal Neoplasms; Deoxyuridine; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Middle Aged; Sex Factors; Tandem Mass Spectrometry; Tetrahydrofolates | 2021 |
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Deoxyuridine; Disease-Free Survival; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Survival Rate; Treatment Outcome | 2018 |
Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Deoxycytidine; Deoxyuridine; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Time Factors | 2000 |
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Colorectal Neoplasms; Deoxyuridine; Enzyme Inhibitors; Fluorouracil; Humans; Infusions, Intravenous; Quinazolines; Thiophenes; Thymidylate Synthase | 2002 |
7 other study(ies) available for deoxyuridine and Colorectal Neoplasms
| Article | Year |
|---|---|
A Nucleoside Derivative 5-Vinyluridine (VrU) for Imaging RNA in Cells and Animals.
Topics: Animals; Cell Proliferation; Colorectal Neoplasms; Deoxyuridine; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; RNA, Neoplasm; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Caenorhabditis elegans; Camptothecin; Colorectal Neoplasms; Comamonas; Deoxyuridine; Diet; Escherichia coli; Fluorouracil; Gastrointestinal Microbiome; Humans; Models, Animal; Pyrimidine Nucleosides | 2017 |
DNA-based nanoscaffolds as vehicles for 5-fluoro-2'-deoxyuridine oligomers in colorectal cancer therapy.
Topics: Cell Line, Tumor; Cholesterol; Colorectal Neoplasms; Deoxyuridine; DNA; Drug Resistance, Neoplasm; Fluorouracil; Humans; Nanostructures | 2018 |
DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Deoxyuridine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Male; Mice, Nude; Middle Aged; RNA, Messenger | 2018 |
Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo.
Topics: Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Cohort Studies; Colorectal Neoplasms; Deoxyuridine; Enhancer Elements, Genetic; Female; Fluorouracil; Gene Expression Regulation, Enzymologic; Genes, Reporter; Genotype; HCT116 Cells; HeLa Cells; Humans; Male; Middle Aged; New South Wales; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Tandem Repeat Sequences; Thymidylate Synthase; Transfection; Upstream Stimulatory Factors | 2011 |
Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Deoxyuridine; Female; Fluorouracil; Humans; Male; Thymidine | 2007 |
Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling.
Topics: Apoptosis; Carcinoma; Colon; Colonic Polyps; Colorectal Neoplasms; Deoxyuridine; Epithelium; Humans; Hyperplasia; Intestinal Mucosa; Neoplasm Staging; Reference Values; Staining and Labeling | 1996 |